News

MaxiVision Eye Hospitals accomplished yet another milestone, successfully carried out ARMD surgery in Hyderabad

1st Eye hospital in India to conduct such an operation

Hyderabad-based MaxiVision Super Specialty Eye Hospital takes pride to announce yet another milestone it accomplished having successfully done ARMD (Age Related Macular Degeneration) surgery a first of its kind operation in India and created a history by improving vision to patient suffering from the problem for more than 40 years who has lost his hopes moving various hospitals and counties like USA. Dr.Kasu Prasad Reddy – Founder & Mentor, Maxivision Eye Hospital Group known for his rich experience in carrying out critical eye care surgeries triumphantly conducted this operation on one RVS Subbaraju 72 years old from Hyderabad and became the 1st eye doctor in India to perform such a surgery. MaxiVision is the first eye hospital in India to accomplish this milestone. Patient RVS Subbaraju ,A professor in Chemical engineering exulted in happy on regaining vision after 40 years of struggle said,he has lost hopes on the eyes problem as there is no cure for ARMD and moved many hospitals to get it rectified but in vain. Finally he got successfully operated in MaxiVsion and his vision has been improved a lot.

maxvsion

Maxivision Super Specialty Eye Hospital founded by Dr. Kasu Prasad Reddy is at the forefront of many indigenous research projects and introduced many proven technologies to improve the vision of patients.  Continuing the tradition of brining advanced technologies for patient care, Maxivision in collaboration with Care Group IOL, an Indian Company based in Vadodara, Gujarat and its founder Mr. Lal Dave is proud to announce the introduction of iolAMD® eyemaxmonoTM lens technology invented by Dr. Qureshi and Dr. Artal for the first time in India for the treatment of macular degeneration.

Speaking on the occasion Dr.Kasu Prasad Reddy – Founder & Mentor, Maxivision Eye Hospital Group, said, ARMD is a condition wherein if you would imagine the eye like a camera with a lens in the front to focus and a film in the back for processing the picture, the film part of the eye is the Retina which has two parts – central retina and peripheral retina. The central retina is called the Macula and is responsible for central vision. When you directly look at people or paper, Macula is primarily responsible to see sharply whether it is near or distant. This macula in some people degenerates and loses its ability to focus sharply as they become older,and in these people even if a cataract operation is done, the central vision remains to be defective. Therefore, as it is related to age problem, it is called Age Related Macular Degeneration or ARMD. For the 1st time in India an Indian company the Care group India, of Baroda in Gujarat has produced a lens that was invented jointly by Dr.Bobby Qureshi of London along with Prof.Pablo Artal of Murcia University and Care group india.They have produced a lens called IOL AMD. The ability of the lens is such and the optics are designed in such a way that the image we see is focused into the peripheral part of the deceased macula, so that the patient gets improvement in the ability to see the near and the distance.

Elaborating more Sudheer, COO of Maxivision Eye Hospital Group, said, for the 1st time in India Maxivision Eye Hospital has conducted many researches and introduced many technologies, got the opportunity, to take up this surgery, thanks to care group india and its Founder Mr Lal Dave. Our Founder Dr.Kasu Prasad Reddy has conducted this very 1stoperation in India.

Maxivision is focused on providing best quality eye treatment with state of the art technology and inputs. While similar technologies are available in many other places, Maxivision is choicest destination for quality treatment due to experience of our surgeons and number of eyes we have treated and gave quality vision. Our stringent quality check parameters, and exemplary treatment results have helped increase our patient flow.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn0Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top